Toripalimab Plus Chemotherapy for Recurrent or Metastatic Nasopharyngeal Carcinoma: The JUPITER-02 Randomized Clinical Trial.
Mai HQ, Chen QY, Chen D, Hu C, Yang K, Wen J, Li J, Shi Y, Jin F, Xu R, Pan J, Qu S, Li P, Hu C, Liu YC, Jiang Y, He X, Wang HM, Lim WT, Liao W, He X, Chen X, Wang S, Yuan X, Li Q, Lin X, Jing S, Chen Y, Lu Y, Hsieh CY, Yang MH, Yen CJ, Samol J, Luo X, Wang X, Tang X, Feng H, Yao S, Keegan P, Xu RH.
Mai HQ, et al.
JAMA. 2023 Nov 28;330(20):1961-1970. doi: 10.1001/jama.2023.20181.
JAMA. 2023.
PMID: 38015220
Clinical Trial.
DESIGN, SETTING, AND PARTICIPANTS: JUPITER-02 is an international, multicenter, randomized, double-blind phase 3 study conducted in NPC-endemic regions, including mainland China, Taiwan, and Singapore. From November 10, 2018, to October 20, 2019, 289 patients with RM-NPC w …
DESIGN, SETTING, AND PARTICIPANTS: JUPITER-02 is an international, multicenter, randomized, double-blind phase 3 study conducted in NPC-ende …